Biomind Labs Inc. reported earnings results for the third quarter and nine months ended September 30, 2025. For the third quarter, the company reported net loss was USD 0.102756 million compared to USD 0.034529 million a year ago. Basic loss per share from continuing operations was USD 0.001.
For the nine months, net loss was USD 0.286063 million compared to USD 0.432744 million a year ago.